SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001600132-23-000021
Filing Date
2023-03-06
Accepted
2023-03-06 16:25:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tmb-20230306x424b5.htm 424B5 504211
2 GRAPHIC tmb-20230306x424b5001.jpg GRAPHIC 11036
3 GRAPHIC tmb-20230306x424b5003.jpg GRAPHIC 11006
  Complete submission text file 0001600132-23-000021.txt   535971
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239473 | Film No.: 23709264
SIC: 2834 Pharmaceutical Preparations